Invitation to the Alumni Breakfast Speaker Series
November 14, 2007

Micheál J. Kelly, Dean, Telfer School of Management and John Reid, President, CATAAllianceare pleased to welcome our guest speaker: Dr. Frank R. Lichtenberg,Courtney C. Brown Professor of Business, Columbia University Graduate School of Business, Discussing: “The impact of new drugs on longevity and medical expenditure”.

Date: Thursday, November 29, 2007
Time: 7:00 a.m. Coffee and networking
7:30 a.m. Sit-down breakfast
8:00 a.m. to 9:00 a.m. Presentation
Location: Telfer School of Management
Desmarais Building, room 4101 4th Floor
55 Laurier E.,
Ottawa ON
K1N 6N5
(“Pay and Display” parking available under Desmarais Building)
Cost: $30 per person
$25 for uOttawa students and alumni and CATA Members

Register early. Seats are limited.(Payable in advance by MasterCard, Visa, cash or cheque.)No-shows will be billed. Substitutions are allowed at any time.
Registration: Register online: http://www.alumboutique.ca/Click English, Events, Ottawa Area Events

Contact Us:
Telfer School of Management
Alumni Breakfast Speaker Series
55 Laurier East,
Ottawa, Ontario K1N 6N5
Tel.: (613) 562-5800 x 2396
Fax: (613) 562-5332
alumni@telfer.uOttawa.ca

Biography:

Dr. Frank R. Lichtenberg,
Courtney C. Brown Professor of Business,
Columbia University Graduate School of Business.

Frank R. Lichtenberg is Courtney C. Brown Professor of Business at the Columbia University Graduate School of Business, and a Research Associate of the National Bureau of Economic Research. He received a BA with Honors in History from the University of Chicago and an MA and PhD in Economics from the University of Pennsylvania.

Mr. Lichtenberg previously taught at Harvard University and the University of Pennsylvania. He has served as an expert for the Federal Trade Commission, the U.S. Dept. of Justice, and state Attorneys General, and has testified before Congress. He has worked for several U.S. government agencies, including the Department of Justice, the Congressional Budget Office, and the Census Bureau, and been a visiting scholar at the Wissenschaftszentrum Berlin, the University of Munich, and elsewhere.Some of Professor Lichtenberg’s research has examined how the introduction of new technology arising from research and development affects the productivity of companies, industries and nations. Recently he has performed studies of the impact of pharmaceutical innovation on longevity, the effect of computers on productivity in business and government organizations, and the consequences of takeovers and leveraged buyouts for efficiency and employment. His articles have been published in numerous scholarly journals and in the popular press. His book Corporate Takeovers and Productivity has been published by MIT Press. He was awarded the 1998 Schumpeter Prize for his paper, Pharmaceutical Innovation as a Process of Creative Destruction, and a 2003 Milken Institute Award for Distinguished Economic Research for the paper, Pharmaceutical Knowledge-Capital Accumulation and Longevity.

He has been awarded research fellowships, grants, and contracts by the National Science Foundation, the National Institute of Standards and Technology, Merck and Co., the Fulbright Commission, the Brookings Institution, the Alfred P. Sloan Foundation, The German Marshall Fund, the American Enterprise Institute, and other organizations. He has served as a consultant to private organizations and government agencies including the Securities Industry Association, Pfizer, Inc., the Community Preservation Corporation, the RAND Corporation, the New York City Water Board, Touche Ross and Co., The Walt Disney Company, McGraw-Hill, and the National Pharmaceutical Council. He is a Director of the economics consulting firm LECG, LLC.

Event Partners: